Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

21,337 total articles

Beam Global Reports First Quarter 2026 Operating Results

Beam Global Reports First Quarter 2026 Operating Results

Beam Global announced its Q1 2026 operating results showing a 51% revenue decline to $3.1 million, primarily due to order timing, seasonal slowdowns in Europe, and reduced U.S. federal EV infrastructure spending. However, the company experienced a 50% increase in backlog to $9 million and Q2 revenue through mid-May has already surpassed Q1 totals. …

Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

Allarity Therapeutics, a Nasdaq-listed clinical-stage biopharma company, reported Q1 2026 financial results and significant progress in its lead drug stenoparib's development. Clinical trials are advancing in relapsed small cell lung cancer and advanced ovarian cancer with FDA Fast Track designation. The company received a patent Notice of Allowanc…

XMax Inc. Announces First Quarter 2026 Financial Results

XMax Inc. Announces First Quarter 2026 Financial Results

XMax Inc. announced its Q1 2026 financial results, achieving profitability despite a revenue decline in the furniture segment. The company is strategically expanding into artificial intelligence through a new subsidiary and multiple agreements to develop AI platforms and services, supported by a strengthened balance sheet due to recent capital rais…

FSI ANNOUNCES FIRST QUARTER, 2026 FINANCIAL RESULTS

FSI ANNOUNCES FIRST QUARTER, 2026 FINANCIAL RESULTS

Flexible Solutions International, developer of biodegradable polymers and environmental technologies, reported an 11% increase in Q1 2026 sales compared to the prior year, narrowing net losses and improving operating cash flow despite significant expansion costs. The company highlights steady production increases from new contracts and growth oppor…

EagleNXT Provides Shareholder Update as Second Quarter Momentum Builds Across Defense and Commercial Markets

EagleNXT Provides Shareholder Update as Second Quarter Momentum Builds Across Defense and Commercial Markets

EagleNXT (NYSE: UAVS) reported strong second-quarter momentum driven by three U.S. Army awards, commencement of U.S.-based production in Allen, Texas, and launch of a counter-drone joint venture. The company is advancing its position in defense and commercial drone markets through increased domestic manufacturing, strategic partnerships, and new pr…

GSR V Acquisition Corp. Announces the Closing of its $230 Million Initial Public Offering, Including Full-Exercise Of Over-Allotment Option

GSR V Acquisition Corp. Announces the Closing of its $230 Million Initial Public Offering, Including Full-Exercise Of Over-Allotment Option

GSR V Acquisition Corp., a Cayman Islands-based blank check company, successfully closed its initial public offering on May 15, 2026, raising $230 million through the sale of 23 million units at $10 each. The IPO included the full exercise of the underwriter's overallotment option, and the units began trading on Nasdaq under the ticker GSRVU. The c…

Cemtrex Reports Fiscal Year 2026 Second Quarter Financial Results

Cemtrex Reports Fiscal Year 2026 Second Quarter Financial Results

Cemtrex, Inc. reported its fiscal year 2026 second quarter financial results, showcasing growth in its Industrial Services segment and the launch of its Aerospace & Defense segment following recent acquisitions. The company improved its Security segment margins through pricing and cost reduction initiatives, strengthened its balance sheet significa…

EHang Files Annual Report on Form 20-F for Fiscal Year 2025

EHang Files Annual Report on Form 20-F for Fiscal Year 2025

EHang Holdings Limited, a pioneer in advanced air mobility technology, announced the filing of its annual report on Form 20-F for fiscal year 2025. The report details the company's continued development and commercialization of pilotless electric vertical take-off and landing aircraft, including certifications received and operational progress in C…

Maris-Tech Announces Full-Year 2025 Financial Results and Continued Strategic Focus on AI-Powered Edge Video Solutions

Maris-Tech Announces Full-Year 2025 Financial Results and Continued Strategic Focus on AI-Powered Edge Video Solutions

Maris-Tech Ltd. announced its 2025 financial results showing revenues dropped sharply to $1.34 million from $6.08 million in 2024, with a net loss escalating to $5.41 million. Despite financial challenges, the company remains committed to developing compact, low-power AI-driven edge video technology targeting defense and homeland security sectors, …

Banzai Reports First Quarter 2026 Financial Results

Banzai Reports First Quarter 2026 Financial Results

Banzai International, Inc. reported first quarter 2026 financial results with revenue of $2.7 million, a 4% decrease from Q4 2025, and a net loss of $8.4 million. The company signed a non-binding letter of intent to acquire assets of AI sales enablement platform ConnectAndSell to boost revenue and expand AI capabilities. Banzai continues to manage …

Micware Co., Ltd. Announces Closing of Upsized Initial Public Offering

Micware Co., Ltd. Announces Closing of Upsized Initial Public Offering

Micware Co., Ltd., a Japan-based automotive and mobility software provider, successfully closed an upsized initial public offering on the Nasdaq Global Market, issuing 2,850,000 ADSs at $8.00 each, totaling approximately $22.8 million in gross proceeds. The company plans to leverage the funds to expand its proprietary in-vehicle infotainment softwa…

Greenlane Reports First Quarter 2026 Financial Results

Greenlane Reports First Quarter 2026 Financial Results

Greenlane Holdings, Inc. reported its first quarter 2026 financial results highlighting its adoption of a digital asset treasury strategy centered on the acquisition and management of BERA tokens. The company increased BERA holdings and BERA-per-share by approximately 44%, generated staking revenue, but experienced a 70% decline in net revenue comp…

Enlivex Announces Receipt of Nasdaq Minimum Bid Price Notification

Enlivex Announces Receipt of Nasdaq Minimum Bid Price Notification

Enlivex Ltd., a Nasdaq-listed quality longevity company, received a Nasdaq notification indicating its stock has fallen below the required $1.00 minimum bid price. The company has 180 days to raise its share price above the threshold or potentially face delisting, with possible options including a reverse stock split. The notice does not currently …

Outlook Therapeutics Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update

Outlook Therapeutics Reports Second Quarter Fiscal Year 2026 Financial Results and Provides Corporate Update

Outlook Therapeutics reported its fiscal Q2 2026 financial results, highlighting a net loss reduction compared to last year and progress in commercializing LYTENAVA™ (bevacizumab gamma) in Europe including a new partnership in Switzerland. The company completed a formal dispute resolution meeting with the FDA regarding its U.S. approval application…

Cerebras Systems Announces Closing of Initial Public Offering

Cerebras Systems Announces Closing of Initial Public Offering

Cerebras Systems Inc. has completed its initial public offering of 34.5 million Class A common shares at $185 each, raising approximately $6.38 billion in gross proceeds. The company's stock began trading on Nasdaq under the ticker CBRS. Cerebras specializes in AI infrastructure with its flagship Wafer-Scale Engine 3 processor, which is significant…

Solana Company Reports First Quarter 2026 Financial Results

Solana Company Reports First Quarter 2026 Financial Results

Solana Company (NASDAQ: HSDT) reported Q1 2026 revenue of $3.6 million primarily from staking rewards, a substantial increase from the previous year. Despite strong gross profits, the company reported a net loss of $99.8 million due to large non-cash unrealized digital asset losses and operational expenses. The company continued capital allocation …

Binah Capital Group Reports Results for First Quarter of 2026

Binah Capital Group Reports Results for First Quarter of 2026

Binah Capital Group, Inc. announced its first quarter 2026 results marked by a 12.9% increase in assets under management to $29.0 billion, a near doubling of net income to $1.9 million, and a 50% increase in EBITDA compared to the prior year period. Despite stable total revenues around $48.7 million, the company achieved higher profitability and st…

Covenant Logistics Group Announces Quarterly Cash Dividend

Covenant Logistics Group Announces Quarterly Cash Dividend

Covenant Logistics Group, Inc. announced a quarterly cash dividend of $0.07 per share for both Class A and Class B common stock, payable on June 26, 2026, to shareholders of record as of June 5, 2026. The dividend distribution aligns with the company's approved cash dividend program, though future dividends remain subject to board approval and fina…

Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout

Plus Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update on REYOBIQ™ Clinical Program and CNSide® Commercial Rollout

Plus Therapeutics announced its first quarter 2026 financial results highlighting progress in its CNSide commercial expansion and REYOBIQ clinical development programs. The company secured FDA Orphan Drug Designation for REYOBIQ in pediatric malignant gliomas, expanded payer coverage for CNSide to approximately 81 million covered lives, and complet…

Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints in Patients from Phase 3 Trial of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer Under Prolonged Follow-up at AUA 2026 Annual Meeting

Candel Therapeutics Reports Extended Clinical Benefit Over Multiple Clinical Endpoints in Patients from Phase 3 Trial of Aglatimagene Besadenovec (CAN-2409) in Localized Prostate Cancer Under Prolonged Follow-up at AUA 2026 Annual Meeting

Candel Therapeutics reported extended phase 3 clinical trial results for its lead immunotherapy candidate, aglatimagene besadenovec (CAN-2409), in intermediate- to high-risk localized prostate cancer. After a median of 58 months follow-up, the therapy demonstrated a statistically significant 39% improvement in prostate cancer-specific disease-free …

Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition

Rani Therapeutics Reports First Quarter 2026 Financial Results; Provides Corporate Update; Announces CFO Transition

Rani Therapeutics released its Q1 2026 financial results, highlighting progress in its Phase 1 clinical study of RT-114, an oral obesity treatment using its RaniPill® technology in collaboration with ProGen. The company appointed key strategic executives and announced a CFO transition while maintaining adequate cash to fund operations into late 202…